Finding 525617 (2024-002)

Significant Deficiency
Requirement
I
Questioned Costs
$1
Year
2024
Accepted
2025-03-04
Audit: 344717
Organization: Esperanza Health Centers (IL)

AI Summary

  • Core Issue: The Organization failed to verify if a vendor was suspended or debarred before entering into a contract.
  • Impacted Requirements: Compliance with 2 CFR sections 200.212, 200.318(h), and 180.300, which mandate vendor verification.
  • Recommended Follow-Up: Update procurement policies to include mandatory checks for vendor suspension or debarment status.

Finding Text

Suspension and Debarment Federal Agency: U.S. Department of Health and Human Services Federal Program Name: Health Center Infrastructure Support Assistance Listing Number: 93.526 Federal Award Identification Number: C8ECS44866-01-00 Award Periods: September 15, 2021 – September 14, 2024 Type of Finding: Immaterial noncompliance and significant deficiency in internal control over compliance Criteria: 2 CFR sections 200.212 and 200.318(h); 2 CFR section 180.300; 48 CFR section 52.209-6 outlines that the non-Federal entity must verify that the agency in which it is entering into a contract is not suspended or debarred or otherwise excluded from participating in the transaction. Condition: The Organization did not check to see if a vendor was suspended or debarred prior to entering a contract with the vendor. Questioned Costs: $38,515. Context: The Organization purchased medical equipment from a vendor without first verifying the vendor was not suspended or debarred. Cause: Oversight Effect: Formalized procedures should be in place to ensure the Organization does not engage with a vendor that is debarred, suspended, or otherwise excluded. Repeat Finding: No. Recommendation: CLA recommends the Organization update its procurement policy to include procedures that a vendor be verified as not being debarred, suspended, or excluded. Views of Responsible Officials: There is no disagreement with the audit finding.

Corrective Action Plan

Action taken in response to finding: Esperanza will: 1. For new vendors – review if the vendor is included in the federal list of debarred, suspended, or excluded vendors 2. For existing vendors – review, on an annual basis, if vendors are included in the federal list of debarred, suspended, or excluded vendors Name(s) of the contact person(s) responsible for corrective action: Ryan Gadia Planned completion date for corrective action plan: June 30, 2025

Categories

Questioned Costs Procurement, Suspension & Debarment

Other Findings in this Audit

  • 525615 2024-001
    Significant Deficiency
  • 525616 2024-001
    Significant Deficiency
  • 1102057 2024-001
    Significant Deficiency
  • 1102058 2024-001
    Significant Deficiency
  • 1102059 2024-002
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.493 Congressional Directives $982,182
93.526 Fip Verification $784,731
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $686,206
93.224 Community Health Centers $430,205
21.027 Coronavirus State and Local Fiscal Recovery Funds $303,256
93.391 Activities to Support State, Tribal, Local and Territorial (stlt) Health Department Response to Public Health Or Healthcare Crises $118,502
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $85,998
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation�s Health $75,000
93.914 Hiv Emergency Relief Project Grants $71,737
93.185 Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects $68,586